Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Steven Idell
University of Texas Hlth Ctr at Tyler, Department: None
Should you be removed from our database? Contact us at [email protected]. Read more below.
Lung Therapeutics, Inc. (LTI)
Other : Member of Board of Directors, LTI Chief Scientifice Officer, Creator of IP licensed for LTI, Investigator on research involving licensed IP
Investigator and IP creator for use of scuPA and CSP7 in pleural loculation, for use of a peptide to reduce pulmonary scarring associated with interstitial lung diseases. Both interventions are patented and licensed to LTI.
Control of fibrosing lung disease by p53-miR-34a-targeted therapeutics
Idiopathic pulmonary fibrosis is a poorly understood fatal scarring disorder of the lungs for which there is no cure. Increased activation, proliferation, migration and deposition of matrix proteins by lung fibroblasts contribute to progressive loss of lung architecture and function. We will elucidate how the tumor suppressor protein p53 and microRNA-34a interact with signaling intermediaries to contribute to the pathogenesis of pulmonary fibrosis and test interventions that target this pathway to reverse lung scarring.
Filed on May 14, 2019.
Tell us what you know about Steven Idell's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Steven Idell”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Steven Idell | University of Texas Hlth Ctr at Tyler | Conflict of Interest | Lung Therapeutics Inc. (LTI) | $0 - $4,999 |
| Steven Idell | University of Texas Hlth Ctr at Tyler | Financial Disclosure | Lung Therapeutics, Inc. | |
| Steven Idell | University of Texas Hlth Ctr at Tyler | Financial Disclosure | Lung Therapeutics, Inc. | |
| Steven Idell | University of Texas Hlth Ctr at Tyler | Financial Disclosure | Intellectual Property (No related entity) | |
| Steven Idell | University of Texas Hlth Ctr at Tyler | Financial Disclosure | Lung Therapeutics, Inc. | |
| Steven Idell | University of Texas Hlth Ctr at Tyler | Financial Disclosure | Lung Therapeutics, Inc. | |
| Steven Idell | University of Texas Hlth Ctr at Tyler | Financial Disclosure | Lung Therapeutics, Inc. | |
| Steven Idell | University of Texas Hlth Ctr at Tyler | Financial Disclosure | Lung Therapeutics, Inc. | |
| Steven Idell | University of Texas Hlth Ctr at Tyler | Financial Disclosure | Lung Therapeutics, Inc. | |
| Steven Idell | University of Texas Hlth Ctr at Tyler | Financial Disclosure | Lung Therapeutics, Inc. |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.